companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

CZINKOTA ENGINEERING SVC

THUNDER BAY-Canada

Company Name:
Corporate Name:
CZINKOTA ENGINEERING SVC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 500 May St N,THUNDER BAY,ON,Canada 
ZIP Code:
Postal Code:
P7C3R6 
Telephone Number: 8076225464 
Fax Number: 8076235426 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
871106 
USA SIC Description:
Engineers 
Number of Employees:
1 to 4 
Sales Amount:
Less than $500,000 
Credit History:
Credit Report:
Good 
Contact Person:
Sid Czinkota 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
CZOLPINSKI THADDEUS DR CARDIOLOGIST
CZOLPINSKI, TED MD
CZINKOTA ENGINEERING SERVICES
Next company profile:
CZARNECKI JAN DR OPHTHALMOLOGIST
CZARNECKI, JAN MD
CYSTIC FIBROSIS FOUNDATION










Company News:
  • Biologics for eosinophilic oesophagitis: a systematic review and meta . . .
    Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred research into targeted biological therapies, while the conclusive therapeutic efficacy of biologics remains uncertain In this review, we conducted a meta-analysis of all RCTS of biologics in the treatment of EoE to evaluate their
  • Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?
    Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including dysphagia and food impaction 1,2 The incidence and prevalence of EoE are rising and untreated disease can lead to significant esophageal stenosis 2,3 Standard treatments include proton-pump inhibitors (PPIs), swallowed topical
  • Current state of biologics in treating eosinophilic esophagitis
    Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated This review focuses on biologics therapy in EoE
  • DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
    Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb (15kg) Serious side effects can occur Please see Important Safety Information and Prescribing Information and Patient Information on website
  • Biologics for eosinophilic oesophagitis: a systematic review . . . - PubMed
    Our findings suggest that the biologics currently being investigated are considered safe and effective treatments for EoE, while their efficiency varies However, the discussion of biologics in non-pharyngitis EGID is hampered by a lack of research, necessitating more research in high-quality trials …
  • Biologics in Eosinophilic Esophagitis — Ready for Prime Time?
    Eosinophilic esophagitis is an immune-mediated, chronic, inflammatory disease of the esophagus that was first recognized as a distinct entity less than three decades ago 1 The immunopathogenesis of
  • Consumer’s Guide to Biologics for Eosinophilic Esophagitis
    The Consumer’s Guide to Biologics for Eosinophilic Esophagitis Learn everything you need to know about the first FDA-approved treatment for eosinophilic esophagitis
  • Biologics in eosinophilic esophagitis - PubMed
    Biologics for treatment of EoE may result in symptom and histologic improvement and has the potential to treat disease with minimal side effects
  • Eosinophilic esophagitis: promising therapy, biomarkers, and assessment . . .
    The recent approval of dupilumab for treatment of eosinophilic esophagitis (EOE), research into better biomarkers, and the anticipated availability of a metric to assess EOE severity all bode well for patients Speakers considered the ramifications of these developments Breakthroughs in biologic therapy for eosinophilic esophagitis Biologics and other novel therapies are needed for treatment
  • Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A . . .
    Eosinophilic esophagitis (EoE) can be treated using a wide range of therapies, including dietary elimination, acid suppression, steroids, and more recently, biologic medications In this review, the authors aim to provide an overall review of EoE therapeutics both in use and in clinical development in pediatrics and adults 2




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer